| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6168758 | Urology | 2011 | 7 Pages |
Abstract
The present study demonstrates synergistic efficacy of pazopanib with docetaxel in docetaxel-resistant bladder cancer cells. This work supports future evaluation of pazopanib with docetaxel for the treatment of bladder cancer with the potential of improved efficacy and toxicity.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Yuan Li, Xiaoping Yang, Lih-Jen Su, Thomas W. Flaig,